Media Center

Latest from the Blogs

  1. January 14, 2021

    NBTS Brain Tumor Clinical Trials Report: Q4 2020

    It can be hard to keep track of new clinical trial opportunities opening across the United States, especially during the current public health crisis created by the coronavirus (COVID-19). However, there are many clinical trials still actively enrolling patients, and this report provides a summary of the studies that have recently opened or started for […]

    Read more | 
  2. January 7, 2021

    New Treatment Arms Opening for Patients in NBTS-Funded GBM AGILE Clinical Trial

    Yesterday, it was announced that the GBM AGILE adaptive clinical trial platform is opening two new treatment arms, with one evaluating Kintara Therapeutics’s chemotherapy, VAL-083, and Kazia Therapeutics’s targeted therapy, paxalisib.  “NBTS has long supported GBM AGILE as a scientifically cutting-edge and more patient-friendly way to develop and evaluate emerging new treatments for patients,” says […]

    Read more | 

Media Contacts

If you need additional information, have a specific request, or would like a comment from National Brain Tumor Society, please use the contacts below:

Tom Halkin
Senior Manager of Communications
617 393 2849
thalkin@braintumor.org

Share